Search / Trial NCT06235827

Effects of Green Tea Consumption on Primary Glaucoma

Launched by UNIVERSITI SAINS MALAYSIA · Jan 29, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Description

Glaucoma is a progressive optic neuropathy characterised by loss of retinal ganglion cells (RGCs) with corresponding visual field loss. The current established treatment of glaucoma is by reducing IOP, as one of neuroprotectant factor to prevent further loss RGCs. However, it is not always sufficient to fully prevent disease progression. Oxidative stress is one of biological insult contribute to etiology and progression of glaucoma. Antioxidants represent the first line of defence against oxidative stress and are obtained through the diet and produced internally has shown to be protective t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patient with confirmed diagnosis of primary glaucoma (POAG/PACG/NTG) that achieve target IOP with medical therapy at least for 6 months.
  • * Never consume green tea as daily drinks.
  • Exclusion Criteria:
  • * Dense cataract with Lens Opacity Classification Sytem (LOCS II) of more than grade 2
  • * Any other ocular media opacity that may interfere with OCT imaging ( eg: cornea scar/vitreous haemorrhage)
  • * Any history of optic neuropathy
  • * History of glaucoma or retinal surgery
  • * Macular degeneration and retinal disorder
  • * Patient with caffein sensitive that causes unpleasant reaction (eg: palpitation, insomnia, nausea, constipation)
  • * Allergic to green tea

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Kubang Kerian, Kelantan, Malaysia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0